Matches in Wikidata for { <http://www.wikidata.org/entity/Q97520599> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q97520599 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97520599 description "im Juli 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q97520599 description "scientific article published on 06 July 2020" @default.
- Q97520599 description "wetenschappelijk artikel" @default.
- Q97520599 description "наукова стаття, опублікована 6 липня 2020" @default.
- Q97520599 name "ANCA-ASSOCIATED VASCULITIDES: RECOMMENDATIONS OF THE FRENCH VASCULITIS STUDY GROUP ON THE USE OF IMMUNOSUPPRESSANTS AND BIOTHERAPIES FOR REMISSION INDUCTION AND MAINTENANCE" @default.
- Q97520599 name "ANCA-ASSOCIATED VASCULITIDES: RECOMMENDATIONS OF THE FRENCH VASCULITIS STUDY GROUP ON THE USE OF IMMUNOSUPPRESSANTS AND BIOTHERAPIES FOR REMISSION INDUCTION AND MAINTENANCE" @default.
- Q97520599 type Item @default.
- Q97520599 label "ANCA-ASSOCIATED VASCULITIDES: RECOMMENDATIONS OF THE FRENCH VASCULITIS STUDY GROUP ON THE USE OF IMMUNOSUPPRESSANTS AND BIOTHERAPIES FOR REMISSION INDUCTION AND MAINTENANCE" @default.
- Q97520599 label "ANCA-ASSOCIATED VASCULITIDES: RECOMMENDATIONS OF THE FRENCH VASCULITIS STUDY GROUP ON THE USE OF IMMUNOSUPPRESSANTS AND BIOTHERAPIES FOR REMISSION INDUCTION AND MAINTENANCE" @default.
- Q97520599 prefLabel "ANCA-ASSOCIATED VASCULITIDES: RECOMMENDATIONS OF THE FRENCH VASCULITIS STUDY GROUP ON THE USE OF IMMUNOSUPPRESSANTS AND BIOTHERAPIES FOR REMISSION INDUCTION AND MAINTENANCE" @default.
- Q97520599 prefLabel "ANCA-ASSOCIATED VASCULITIDES: RECOMMENDATIONS OF THE FRENCH VASCULITIS STUDY GROUP ON THE USE OF IMMUNOSUPPRESSANTS AND BIOTHERAPIES FOR REMISSION INDUCTION AND MAINTENANCE" @default.
- Q97520599 P1433 Q97520599-CDD0FEEF-0F66-4676-8248-2C3D8FBE5E1B @default.
- Q97520599 P1476 Q97520599-4DC94DCE-3510-4B28-872C-15B9B5A76EFE @default.
- Q97520599 P2093 Q97520599-1BD49709-D065-4D9D-BBB1-A15042F62BCC @default.
- Q97520599 P2093 Q97520599-497F9B96-106F-493C-9340-94DAD5CA3D8D @default.
- Q97520599 P2093 Q97520599-6097ADF0-6B5F-41D0-8E6B-E606FE2DD6A5 @default.
- Q97520599 P2093 Q97520599-6134A67E-7713-43D4-A0A6-853BD7591514 @default.
- Q97520599 P2093 Q97520599-6ACD31A3-7911-405F-B93F-597E491C7865 @default.
- Q97520599 P2093 Q97520599-7C6B07A2-78F2-4E9E-9937-729E71F451BF @default.
- Q97520599 P2093 Q97520599-9F17770E-C83B-4CEF-90C6-17A3A9F2919F @default.
- Q97520599 P2093 Q97520599-A705F9DB-CBF4-47C7-A560-691B4072A108 @default.
- Q97520599 P2093 Q97520599-B15307A9-7919-4F15-B83F-8C0B7EC957AB @default.
- Q97520599 P2093 Q97520599-BB3E38E5-8CA7-4D79-9EBF-38E1228396CE @default.
- Q97520599 P2093 Q97520599-C1E7B01B-9753-4616-A272-D826647319B1 @default.
- Q97520599 P2093 Q97520599-CAD78895-0185-4778-BE8E-03E6B9853801 @default.
- Q97520599 P2093 Q97520599-DA0AFAE2-A580-4678-87F9-AEC413045515 @default.
- Q97520599 P2093 Q97520599-F220C93B-3656-4305-A936-458AE1D3FEE5 @default.
- Q97520599 P2093 Q97520599-FD00E532-E10C-44A5-A7BE-D4C7FF173A75 @default.
- Q97520599 P304 Q97520599-C33D30C9-4A42-428D-8CC4-C8B0341A0580 @default.
- Q97520599 P31 Q97520599-9E663EAE-3814-43BE-8420-11DDE01596C0 @default.
- Q97520599 P356 Q97520599-5D91BF95-270D-4826-893E-BF07565FC2D6 @default.
- Q97520599 P50 Q97520599-2FF9D2B0-CAB2-48A6-BF05-8015728A49F3 @default.
- Q97520599 P50 Q97520599-462989EA-3068-42BB-91C5-51C94F4CFB3E @default.
- Q97520599 P50 Q97520599-88B2912E-775B-4326-A8BF-4C9A002962EF @default.
- Q97520599 P577 Q97520599-FBACB315-5D28-426E-92A0-EB9486CC41D6 @default.
- Q97520599 P698 Q97520599-1009F164-D4EA-46D3-8038-C3F862CEC340 @default.
- Q97520599 P356 J.LPM.2020.104031 @default.
- Q97520599 P698 32645418 @default.
- Q97520599 P1433 Q26853799 @default.
- Q97520599 P1476 "ANCA-ASSOCIATED VASCULITIDES: RECOMMENDATIONS OF THE FRENCH VASCULITIS STUDY GROUP ON THE USE OF IMMUNOSUPPRESSANTS AND BIOTHERAPIES FOR REMISSION INDUCTION AND MAINTENANCE" @default.
- Q97520599 P2093 "Benjamin Terrier" @default.
- Q97520599 P2093 "Bernard Bonnotte" @default.
- Q97520599 P2093 "Camillo Ribi" @default.
- Q97520599 P2093 "Cécile-Audrey Durel" @default.
- Q97520599 P2093 "French Vasculitis Study Group/pour le Groupe Français d’Etude des Vascularites (GFEV)" @default.
- Q97520599 P2093 "Frédéric Vandergheynst" @default.
- Q97520599 P2093 "Grégory Pugnet" @default.
- Q97520599 P2093 "Maxime Samson" @default.
- Q97520599 P2093 "Mikael Ebbo" @default.
- Q97520599 P2093 "Noémie Jourde-Chiche" @default.
- Q97520599 P2093 "Olivier Aumaître" @default.
- Q97520599 P2093 "Pierre Charles" @default.
- Q97520599 P2093 "Thomas Quemeneur" @default.
- Q97520599 P2093 "Xavier Puéchal" @default.
- Q97520599 P2093 "Yoann Crabol" @default.
- Q97520599 P304 "104031" @default.
- Q97520599 P31 Q13442814 @default.
- Q97520599 P356 "10.1016/J.LPM.2020.104031" @default.
- Q97520599 P50 Q124182491 @default.
- Q97520599 P50 Q45340353 @default.
- Q97520599 P50 Q88410079 @default.
- Q97520599 P577 "2020-07-06T00:00:00Z" @default.
- Q97520599 P698 "32645418" @default.